Skip to content

The Effect of Consuming a guaraná and Vitamin/Mineral Complex Pre-exercise on Affect, Exertion, Metabolism and Cognition

The Effect of Consuming a Guaraná and Vitamin and Mineral Complex Before a Morning Exercise Session on Affect, Exertion and Substrate Metabolism During Exercise and Cognitive Performance During the Post-exercise Recovery Period

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01929694
Enrollment
40
Registered
2013-08-28
Start date
2013-09-30
Completion date
2014-04-30
Last updated
2014-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Affect and Exertion During and Post-exercise

Brief summary

Consuming a guaraná and vitamin and mineral complex can improve mental fatigue and cognitive function at rest; guaraná also contains caffeine, which can reduce perceived exertion and increase fat burning during exercise. The purpose of this study is to test whether consuming a guaraná and vitamin and mineral product before exercise influences affect (mood), physical exertion and fat burning during exercise and mental fatigue, cognitive performance and affect post-exercise.

Interventions

DIETARY_SUPPLEMENTBerocca Boost
DIETARY_SUPPLEMENTPlacebo

Sponsors

Bayer
CollaboratorINDUSTRY
Northumbria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

Individuals must be: * Healthy * Male * Aged between 18 and 35years * Habitually active (exercising at least twice a week) * Able to run at a moderate pace for 30 minutes non-stop on a treadmill

Exclusion criteria

Individuals will not be eligible to take part in this study if they: * have a history of neurological or psychiatric diseases excluding anxiety or depression * have a current diagnosis of depression or anxiety * have a history of significant head trauma, metabolic, endocrine or cardiac disorders * have smoked within the last 3 months, * have high blood pressure \>140/90mmHg * consume \> 500 mg caffeine per day from all dietary sources * have adverse reactions to caffeine containing products (i.e. tea, coffee, energy drinks, cola, Pepsi) * are currently taking any pharmaceuticals * have habitual taken dietary supplements within the last 4 weeks (defined as ≥3 consecutive days or ≥4 days in total per week) * have current or history of drug or alcohol abuse * have participated in another clinical trial within 30 days prior to screening * have any condition which may interfere with your ability to perform assessments * have any history of hypersensitivity to the investigational product or its active or inactive constituents or any food allergy or intolerance

Design outcomes

Primary

MeasureTime frameDescription
AffectAssessed pre-exercise, at 10min intervals during exercise and 45 and 75min post-exerciseAffect measured using the Feeling Scale and Felt Arousal Scale

Secondary

MeasureTime frameDescription
ExertionMeasured at 10min intervals during exerciseRate of perceived exertion measured using the Borg scale

Other

MeasureTime frameDescription
Cognitive FunctionAssessed at baseline, pre-exercise and immeadiately and 75min post-exerciseParticipants will complete a set of cognitive tasks (Immediate Word Recall, Choice Reaction Time, Rapid visual information processing task, Numeric Working Memory, Delayed word Recall, Word Recognition and Picture Recognition) measuring episodic memory, working memory, attention and decision making.
MoodAssessed at baseline, pre-exercise and immeadiately and 75min post-exerciseAssessed using the Bond-Lader Visual Analogue Scales (VAS) and Energy VAS (concentration, physical stamina, mental stamina)
Substrate MetabolismMeasured at 10min intervals during exerciseMeasured using an online gas analysis system (Cortex). Oxygen uptake, carbon dioxide production, fat and carbohydrate oxidation and energy expenditure will be measured for 1 min at each 10min interval.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026